4 employees
Intellective Bio is a CDMO focusing on biopharmaceutical process development and large-scale production.
2018
$74M
from 2 investors over 2 rounds
Intellective Biologics (Suzhou) Co., Ltd. raised $74M on August 5, 2022
Investors: 北京市富汇创业投资管理有限公司 and Founder Securities Co., Ltd.